Literature DB >> 18399829

Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy.

Robert C Chan1, Daniel A Barocas, Sam S Chang, S Duke Herrell, Peter E Clark, Roxy Baumgartner, Joseph A Smith, Michael S Cookson.   

Abstract

OBJECTIVE: To evaluate the outcomes based on gland size between robotically assisted radical prostatectomy (RALP) and open RP (RRP), as larger prostates might increase the difficulty of RP. PATIENTS AND METHODS: We reviewed 660 patients who had RALP and 340 who had RRP from May 2003 to August 2006; the patients were divided into two groups, with a prostate of >75 and <or=75 g. The clinical characteristics, surgical approach, perioperative and postoperative outcomes were evaluated.
RESULTS: Patients with large prostates were significantly older (P < 0.001), but had a lower pathological stage (RALP, P = 0.046, and RRP, P = 0.008) than patients with small glands, regardless of technique. There was no difference in length of stay or transfusion rates between the groups. A large prostate increased the operative duration of RALP (P < 0.001) but not of RRP. For both RALP and RRP, positive margin rates were lower with larger glands (RALP, P = 0.014; RRP, P = 0.033). Overall, the positive margin rates were lower with RALP (9.9% and 19.0%) than RRP (18.5% and 35.5%) among patients with larger or smaller (P < 0.001) glands, respectively.
CONCLUSIONS: Prostates of >or=75 g had fewer positive margins than smaller glands, regardless of surgical technique. There was also a significant decrease in positive margin rate in among prostates of >75 g in favour of RALP. Thus, RALP appears to be comparable with RRP for patients with large glands, and might reduce the positive margin rate.

Entities:  

Mesh:

Year:  2008        PMID: 18399829     DOI: 10.1111/j.1464-410X.2007.07428.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  [Oncological and functional results of open intrafascial radical prostatectomy].

Authors:  W Y Khoder; A Buchner; S Siegert; C G Stief; B Schlenker
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

Review 2.  Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers.

Authors:  Rafael F Coelho; Bernardo Rocco; Manoj B Patel; Marcelo A Orvieto; Sanket Chauhan; Vincenzo Ficarra; Sara Melegari; Kenneth J Palmer; Vipul R Patel
Journal:  J Endourol       Date:  2010-10-13       Impact factor: 2.942

Review 3.  Comparison of Robot-Assisted Radical Prostatectomy and Open Radical Prostatectomy Outcomes: A Systematic Review and Meta-Analysis.

Authors:  Hyun Ju Seo; Na Rae Lee; Soo Kyung Son; Dae Keun Kim; Koon Ho Rha; Seon Heui Lee
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

Review 4.  Robotic vs. Retropubic radical prostatectomy in prostate cancer: A systematic review and an meta-analysis update.

Authors:  Kun Tang; Kehua Jiang; Hongbo Chen; Zhiqiang Chen; Hua Xu; Zhangqun Ye
Journal:  Oncotarget       Date:  2017-05-09

5.  Can the prophylactic administration of tranexamic acid reduce the blood loss after robotic-assisted radical prostatectomy? Robotic Assisted Radical Prostatectomy with tranEXamic acid (RARPEX): study protocol for a randomized controlled trial.

Authors:  M Balik; J Kosina; P Husek; J Pacovsky; M Brodak; F Cecka
Journal:  Trials       Date:  2022-06-18       Impact factor: 2.728

6.  Technical Tips in Managing Large Median Lobes During Robot-assisted Radical Prostatectomy.

Authors:  Vinayak G Wagaskar; Osama Zaytoun; Priyanka Kale; Adriana Pedraza; Dallin Busby; Avinash Reddy; Ash Tewari
Journal:  Eur Urol Open Sci       Date:  2022-09-23

7.  The surgical learning curve for robotic-assisted laparoscopic radical prostatectomy: experience of a single surgeon with 500 cases in Taiwan, China.

Authors:  Yen-Chuan Ou; Chun-Kuang Yang; Kuangh-Si Chang; John Wang; Siu-Wan Hung; Min-Che Tung; Ashutosh K Tewari; Vipul R Patel
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.